I am an Assistant Professor in Chinese PLA General Hospital. My research interest is drug repositioning. My ORCID ID is 0000-0003-2370-5073. A full list of published articles is shown in Google Scholar.

Selected papers with Reproducible codes:

• 2020 Transcriptome-based drug repositioning for coronavirus disease 2019 (COVID-19)

  • Reproducible research: code

• 2020 Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients

  • Reproducible research (only related to my contributions): code

• 2019 Time-Course Transcriptome Analysis for Drug Repositioning in Fusobacterium nucleatum-Infected Human Gingival Fibroblasts or PubMed

  • Reproducible research: code

• 2019 Transcriptional profiling in the livers of rats after hypobaric hypoxia exposure.

  • Reproducible research: code

• 2016 Cogena, a novel tool for co-expressed gene-set enrichment analysis, applied to drug repositioning and drug mode of action discovery

  • cogena: code or Bioconductor
  • Reproducible research: code

• 2015 Gene Ranking of RNA-Seq Data via Discriminant Non-Negative Matrix Factorization (DNMF)

  • DNMF package: CRAN
  • Reproducible research: code

Meeting with slides:

• Drug repositioning based on coexpressed gene-set enrichment analysis (cogena) at European Bioconductor Developers' Conference 2015

• Co-expressed gene-set enrichment analysis for drug repositioning with examples of psoriasis and periodontal diseases at The 4th Big Data Forum for Life and Health Sciences 2019

Contact:

• Email: zhilongjia#qq.com or jiazhilong#plagh.org